All terms in GO

Label Id Description
interleukin-35 production GO_0070753
The appearance of interleukin-35 due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.
regulation of interleukin-35 production GO_0070754
Any process that modulates the frequency, rate, or extent of interleukin-35 production.
negative regulation of cardiac muscle contraction GO_0055118
Any process that stops, prevents, or reduces the frequency, rate or extent of cardiac muscle contraction.
negative regulation of interleukin-35 production GO_0070755
Any process that stops, prevents, or reduces the frequency, rate, or extent of interleukin-35 production.
regulation of vascular associated smooth muscle cell dedifferentiation GO_1905174
Any process that modulates the frequency, rate or extent of vascular smooth muscle cell dedifferentiation.
positive regulation of interleukin-35 production GO_0070756
Any process that activates or increases the frequency, rate, or extent of interleukin-35 production.
negative regulation of vascular associated smooth muscle cell dedifferentiation GO_1905175
Any process that stops, prevents or reduces the frequency, rate or extent of vascular smooth muscle cell dedifferentiation.
interleukin-35-mediated signaling pathway GO_0070757
The series of molecular signals initiated by interleukin-35 binding to its receptor on the surface of a target cell, and ending with the regulation of a downstream cellular process, e.g. transcription.
RISC complex binding GO_1905172
Binding to a RISC complex.
eukaryotic translation initiation factor 2B complex assembly GO_1905173
The aggregation, arrangement and bonding together of a set of components to form an eukaryotic translation initiation factor 2B complex.
negative regulation of interleukin-35-mediated signaling pathway GO_0070759
Any process that decreases the rate, frequency or extent of an interleukin-35-mediated signaling pathway.
regulation of cardiac muscle tissue regeneration GO_1905178
Any process that modulates the frequency, rate or extent of cardiac muscle tissue regeneration.
negative regulation of cardiac muscle tissue regeneration GO_1905179
Any process that stops, prevents or reduces the frequency, rate or extent of cardiac muscle tissue regeneration.
positive regulation of vascular associated smooth muscle cell dedifferentiation GO_1905176
Any process that activates or increases the frequency, rate or extent of vascular smooth muscle cell dedifferentiation.
otolith mineralization completed early in development GO_0031173
The formation of otoliths during embryogenesis with completion in early postembryonic development. Formation occurs by precipitation of specific crystal forms of calcium carbonate around an organic core of extracellular matrix proteins. Otoconia (otoliths) are small (~10 micron) dense extracellular particles present in the otolith end organs of the vertebrate inner ear.
otolith mineralization GO_0045299
The precipitation of specific crystal forms of calcium carbonate with extracellular matrix proteins in the otolith organs of the vertebrate inner ear.
lifelong otolith mineralization GO_0031174
The formation and growth of otoliths throughout the life of the organism. Otoliths are the large extracellular ear-stones of the fish inner ear, produced by precipitation of specific crystal forms of calcium carbonate on organic matrices. The otolith enlarges throughout the life of the fish, as layers of calcium carbonate are added.
endo-1,4-beta-xylanase activity GO_0031176
Catalysis of the endohydrolysis of (1->4)-beta-D-xylosidic linkages in xylans.
phosphopantetheine binding GO_0031177
Binding to phosphopantetheine, the vitamin pantetheine 4'-(dihydrogen phosphate).
modified amino acid binding GO_0072341
Binding to a modified amino acid.